[Metabolic disorders in dystrophic infants. Lipolysis and insulin secretion].
D000273:Adipose Tissue / Q000187:drug effects; D001835:Body Weight; D003864:Depression, Chemical; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000037:antagonists & inhibitors / Q000097:blood*; D005934:Glucagon / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D007223:Infant; D007228:Infant Nutrition Disorders / Q000378:metabolism*; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D007329:Insulin Antagonists; D000078790:Insulin Secretion; D009539:Nicotinic Acids / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014044:Tolbutamide / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007329:Insulin Antagonists; D009539:Nicotinic Acids; D005934:Glucagon; D014044:Tolbutamide; D005947:Glucose; D009638:Norepinephrine
Stoffwechselstörungen bei dystrophen Säuglingen,. Lipolyse und Insulinsekretion.